OGDEN, Utah, May 27, 1999 (PRIMEZONE) -- Computerized Thermal Imaging, Inc. (OTC BB: COII) (CTI), said today that it has retained the services of Battelle Medical Products, a leading provider of comprehensive product development services to the medical industry, to assist CTI with the formal FDA approval process for the Company's Thermal Breast Imaging System.
"We decided to retain the services of Battelle Medical Products because there is nothing more critical for this company than to successfully complete the submission of clinical data to the FDA as quickly and expeditiously as possible," said David A. Packer, CTI's president. "Battelle is one of the most respected technology companies in the world, having delivered technology-based value to industry and government for nearly 70 years. We believe that by having them as part of our team, we will be able to avoid many of the pitfalls that might cause unanticipated delays in the approval process."
"We are very impressed with the technology that CTI has developed and have already begun to assist them in preparing the clinical data for submission," said Rich Rosen, V.P., & General Manager for Battelle Medical Products. "We believe that CTI's Thermal Breast Imaging System represents a significant development in the early diagnosis of breast cancer. It may also have potential for reducing the costs and trauma of the disease."
CTI is currently seeking FDA approval for its Thermal Breast Imaging System as an adjunctive diagnostic test to mammogram and clinical examination for the detection of breast cancer. The system is currently undergoing multi-center clinical trials to test its efficacy in differentiating benign from malignant breast abnormalities. The system uses a sophisticated heat sensitive camera to record thermal images of breast tissue. These images are then processed with a proprietary computer algorithm designed to recognize the distinct heat signatures of benign and malignant tissue. The test is simple, painless, and requires no exposure to radiation or heat compression.
Computerized Thermal Imaging, Inc. develops and deploys thermal imaging and associated technologies for use in the enhancement of medical screening, diagnosis and patient management. More information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at (801) 776-4700.
Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC.